In particular, the study’s aims were (1) to analyze plasma PCSK9 levels in a cohort of pSS patients free from previous CV in comparison to age- and sex-matched healthy controls (HCs), and (2) to investigate the association between plasma PCSK9 levels and disease-specific parameters of immune dysregulation and measures of atherosclerosis. This evidence concerns the gene PCSK9 and atherosclerosis.